Loss of XIAP sensitizes rosiglitazone-induced growth inhibition of colon cancer in vivo. [electronic resource]
Producer: 20080806Description: 2858-63 p. digitalISSN:- 1097-0215
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Caspase 3 -- metabolism
- Cell Division -- drug effects
- Cell Line, Tumor
- Colonic Neoplasms -- pathology
- Down-Regulation
- Humans
- In Situ Nick-End Labeling
- PPAR gamma -- antagonists & inhibitors
- Rosiglitazone
- Thiazolidinediones -- pharmacology
- X-Linked Inhibitor of Apoptosis Protein -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.